Proactive Investors
16 Jun 2026, 06:39 UTC · 15w ago
Verdict
Headline takes no side. We score IPO +0.60 across three claims — strongly bullish.
+0.60strongly bullish
More positive than 77% of ticker scores this week
Scored by the NIS engine · methodology.
What the story claims
3 claims · scored −1 bearish … +1 bullish
Istesso has commenced dosing patients in a phase II clinical trial for its lead drug candidate, leramistat, targeting sarcopenia caused by rheumatoid arthritis.
More positive than 93% of claims this week
IP Group PLC holds a 56.5% undiluted stake in Istesso.
So whatThe majority stake ensures that a substantial portion of any valuation uplift from the Phase II trial flows directly to IP Group shareholders.
Continue reading
5 related stories
Top 2 movers · tap to explore
More positive than 79% of claims this week
Bango PLC has integrated LinkedIn Premium into its Digital Vending Machine platform for telcos, banks, and retailers.
So whatExpanding the partnership ecosystem increases Bango's product appeal to B2B clients and opens new recurring revenue streams.
More positive than 66% of claims this week
Which stocks this story touches
More positive than 77% of ticker scores this week
The company's portfolio firm, Istesso, has progressed to a phase II clinical trial for its lead drug candidate.
More positive than 71% of ticker scores this week
The company expanded its Digital Vending Machine platform by adding LinkedIn, meeting growing demand for flexible subscription models.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
5h ago
−7.7%
Price is moving against the score
$53.59 vs $58.05 close before publication (Jun 15) · not market-adjusted
IPO chart →
